Sunday, October 5, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

JP Morgan Analyst Maintains Neutral Rating on Tyson Foods with Revised Price Target

Elaine Mendonca by Elaine Mendonca
February 7, 2024
in Breaking News
0
Food Retailers Stock Bull Market
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On February 6, 2024, J.P. Morgan analyst Kenneth Goldman expressed his views on Tyson Foods (NYSE: TSN), maintaining a Neutral rating. In a positive development, Goldman has revised the price target for the stock, increasing it from $55 to $58. This adjustment implies that Goldman anticipates the stock to reach $58 in the future. Consequently, he advises adopting a Neutral stance on Tyson Foods’ shares.

Tyson Foods Inc. (TSN) Stock Drops 3.67% on February 6, 2024; Shows Slight Recovery in After-Hours Trading

On February 6, 2024, Tyson Foods Inc. (TSN) experienced a decline in its stock performance, as reported by CNN Money. TSN is currently trading in the middle of its 52-week range, indicating a relatively stable position within the market. Additionally, it is trading above its 200-day simple moving average, which suggests a positive trend in its stock price.

The price of TSN shares decreased by $2.11 since the market last closed, resulting in a drop of 3.67%. This decline is significant and may have raised concerns among investors.

TSN closed at $55.39, which was the price at the end of the regular trading hours. Despite the drop in price earlier in the day, the stock has shown a slight recovery in after-hours trading, with a rise of $0.25.

While the after-hours increase of $0.25 may indicate a potential rebound, it is essential to consider the overall market conditions and any upcoming news or events that could influence TSN’s stock performance. Investors should conduct thorough research and analysis before making any investment decisions.

Therefore, investors should exercise caution and consult with financial professionals or conduct their own research to make informed investment decisions.

In conclusion, TSN experienced a decline in its stock price on February 6, 2024, with a drop of 3.67%. However, the stock showed a slight recovery in after-hours trading, rising by $0.25. Investors should closely monitor market conditions and company-specific news to gain a comprehensive understanding of TSN’s stock performance and make informed investment choices.

TSN Stock Performance on February 6, 2024: Stagnant Revenue and Decreasing Net Income Raise Concerns

TSN Stock Performances on February 6, 2024: Revenue Stagnant, Net Income Decreases

On February 6, 2024, the stock performance of TSN showed concerning trends in terms of its financials. TSN experienced stagnant total revenue since last year and held flat since the previous quarter. Additionally, the net income for the company decreased significantly, both on a yearly and quarterly basis.

According to data from CNN Money, TSN’s total revenue for the past year amounted to $52.88 billion, with the fourth quarter generating $13.35 billion in revenue. However, these figures remained unchanged from the previous year and quarter, indicating a lack of growth or improvement in the company’s top line.

The net income for TSN showed a concerning decline. Over the past year, TSN reported a net income of -$648 million, which represents a decrease of 120.01% compared to the previous year. In the fourth quarter, the net income was -$450 million, reflecting a 7.91% decrease from the previous quarter. These figures suggest that TSN has faced significant challenges in generating profits and maintaining its financial stability.

Furthermore, the earnings per share (EPS) for TSN also exhibited a negative trend. The EPS for the past year was -$1.87, indicating a decrease of 120.53% compared to the previous year. In the fourth quarter, the EPS remained unchanged at -$1.29, showing no improvement from the previous quarter. Although the EPS did not decline further in the last quarter, it is still a cause for concern, as it remained in negative territory.

Overall, the stock performance of TSN on February 6, 2024, was marked by stagnant total revenue, a significant decrease in net income, and a negative EPS. These figures indicate that TSN has been struggling to generate growth and profitability, potentially raising concerns among investors. It will be crucial for the company to address these challenges and implement strategies to improve its financial performance in the future.

Tags: TSN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Title Missing Bolts and Aviation Safety The Alaska Airlines Boeing 737 Max 9 Incident

EEFT stock news

Analyst Maintains Neutral Rating on FMC with Adjusted Price Target

Alaska Airlines Boeing 737 Investigation Missing Bolts and Safety Measures

Recommended

PepGen Stock

PepGen Shares Face Mounting Pressure Amid Legal Challenges and Pipeline Shift

1 month ago
Technology Artificial intelligence Markets and money

Baidus Stock Soars with Launch of Chinas First 247 Robotaxi Service

2 years ago
Lawson Products Stock

Distribution Solutions Group Faces Profitability Challenge Amid Strong Revenue Growth

1 month ago
Up Fintech Holding Ltd Stock

Up Fintech’s Stellar Earnings Met With Unexpected Market Skepticism

2 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Genomics Leader Illumina Faces Investor Divergence Amid AI Push

Insider Selling Clouds Zscaler’s AI-Driven Rally

Gold ETF Soars as Economic Uncertainty Drives Safe-Haven Demand

Qurate Retail’s Moment of Truth Approaches

A Pivotal Week for Super League Gaming’s Strategic Trajectory

Is Medical Properties Trust Mounting a Sustainable Recovery?

Trending

Cytokinetics Stock
Analysis

Cytokinetics Faces Critical Regulatory Hurdles Amid Promising Drug Data

by Andreas Sommer
October 5, 2025
0

Investors in Cytokinetics are experiencing heightened tension as the biotechnology firm navigates a complex approval pathway for...

Trade Desk Stock

The Trade Desk’s AI Breakthrough Set to Transform Digital Advertising

October 5, 2025
IBM Stock

IBM’s Strategic Pivot: Doubling Down on Enterprise AI and Cloud Infrastructure

October 5, 2025
Illumina Stock

Genomics Leader Illumina Faces Investor Divergence Amid AI Push

October 5, 2025
Zscaler Stock

Insider Selling Clouds Zscaler’s AI-Driven Rally

October 5, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Cytokinetics Faces Critical Regulatory Hurdles Amid Promising Drug Data
  • The Trade Desk’s AI Breakthrough Set to Transform Digital Advertising
  • IBM’s Strategic Pivot: Doubling Down on Enterprise AI and Cloud Infrastructure

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com